Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) CEO Jeffrey Stein bought 8,000 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was purchased at an average cost of $13.21 per share, with a total value of $105,680.00. Following the acquisition, the chief executive officer now directly owns […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) has been assigned a consensus rating of “Buy” from the four ratings firms that are covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]